RNU6-430P

Across TCGA pan-cancer cohorts, RNU6-430P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-430P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where RNU6-430P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-430P is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

UCEC, STAD, and LUSC are the cancer types where RNU6-430P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-430P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+1.270	.007	2	view →
STAD	Male	II,III,IV	+0.432	.016	2	view →
LUSC	All	All	−0.138	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RNU6-430P–UCEC

Open the UCEC breakdown →